Effectiveness of oxaliplatin desensitization protocols. [artículo]
Por: Aguilella Vizcaíno, María José [Farmacia]
| Cortés-Funes Castro, Hernán [Oncología Médica] | Cortijo Cascajares, Susana [Farmacia] | García Escobar, Ignacio [Oncología Médica] | Herreros de Tejada López-Coterilla, Alberto [Farmacia].
Colaborador(es): Servicio de Farmacia Hospitalaria | Servicio de Oncología Médica.
Editor: Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013Descripción: 15(3):219-25.Recursos en línea: Solicitar documento Resumen: INTRODUCTION: Hypersensitivity reaction (HSR) to antineoplastic drugs can force doctors to stop treatment and seek other alternatives. These alternatives may be less effective, not as well tolerated and/or more expensive. Another option is to use desensitization protocols that induce a temporary state of tolerance by gradually administering small quantities of the antineoplastic drug until the therapeutic dosage is reached. The aim of this study is to assess the effectiveness of oxaliplatin desensitization protocols.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC6255 (Navegar estantería) | Disponible |
Formato Vancouver:
Cortijo-Cascajares S, Nacle-López I, García-Escobar I, Aguilella-Vizcaíno MJ, Herreros-de-Tejada A, Cortés-Funes Castro H et al. Effectiveness of oxaliplatin desensitization protocols. Clin Transl Oncol. 2013 Mar;15(3):219-25.
PMID: 22855191
Contiene 32 referencias
INTRODUCTION: Hypersensitivity reaction (HSR) to antineoplastic drugs can force doctors to stop treatment and seek other alternatives. These alternatives may be less effective, not as well tolerated and/or more expensive. Another option is to use desensitization protocols that induce a temporary state of tolerance by gradually administering small quantities of the antineoplastic drug until the therapeutic dosage is reached. The aim of this study is to assess the effectiveness of oxaliplatin desensitization protocols.
No hay comentarios para este ejemplar.